Galmed Pharmaceuticals Ltd.(GLMD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GLMD Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Galmed Pharmaceuticals Ltd. (GLMD), a Healthcare sector company. GLMD is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.0m in revenue. Based on the latest XBRL financial filings (Q4 2025), Galmed Pharmaceuticals Ltd. reports net income of $-4.8M, free cash flow of $-1.9M. Top institutional holders of GLMD by reported 13-F value include TWO SIGMA INVESTMENTS,, XTX Topco Ltd, JANE STREET GROUP,, based on the most recent SEC filings. GLMD trades on the Nasdaq exchange and files with the SEC under CIK 1595353. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GLMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Galmed Pharmaceuticals Ltd. directly from SEC EDGAR.
Net Income
Q4 2025
$-4.8M
Free Cash Flow
Q4 2025
$-1.9M
Get alerted when GLMD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Galmed Pharmaceuticals Ltd. including:
Top Institutional Holders of GLMD
TWO SIGMA INVESTMENTS, LP
$39.3K80,177 shXTX Topco Ltd
$10.8K22,396 shJANE STREET GROUP, LLC
$8.1K16,445 shTWO SIGMA SECURITIES, LLC
$5.9K11,971 shCITADEL ADVISORS LLC
$5.5K11,382 shUBS Group AG
$1.2K2,546 shBNP PARIBAS FINANCIAL MARKETS
$294.00600 shMORGAN STANLEY
$77.00157 shWELLS FARGO & COMPANY/MN
$21.0043 shSBI Securities Co., Ltd.
$8.0016 sh
| Fund | Value | Shares |
|---|---|---|
| TWO SIGMA INVESTMENTS, LP | $39.3K | 80,177 |
| XTX Topco Ltd | $10.8K | 22,396 |
| JANE STREET GROUP, LLC | $8.1K | 16,445 |
| TWO SIGMA SECURITIES, LLC | $5.9K | 11,971 |
| CITADEL ADVISORS LLC | $5.5K | 11,382 |
| UBS Group AG | $1.2K | 2,546 |
| BNP PARIBAS FINANCIAL MARKETS | $294.00 | 600 |
| MORGAN STANLEY | $77.00 | 157 |
| WELLS FARGO & COMPANY/MN | $21.00 | 43 |
| SBI Securities Co., Ltd. | $8.00 | 16 |
More Healthcare Companies
View all Healthcare →Put GLMD on your watchlist
Track score changes the day Galmed Pharmaceuticals Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GLMD a good stock to buy?
13F Pro's AI-powered analysis of Galmed Pharmaceuticals Ltd. (GLMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GLMD are available on the GLMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GLMD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GLMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Galmed Pharmaceuticals Ltd.'s investment landscape.